Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT

S. M. Shettar, L. Grunhaus, A. C. Pande, R. C. Tandon, Ziad Kronfol, R. F. Haskett

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The immediate effects of electroconvulsive therapy (ECT) on cardiac conduction, with or without anticholinergic (glycopyrrolate) premedication, were systematically assessed in 19 patients. The resumption of cardiac rhythm after ECT was significantly delayed in treatments without glycopyrrolate. There was no apparent clinical impact of this phenomenon, even though some patients showed asystole of up to 6 s during nonglycopyrrolate treatments.

Original languageEnglish
Pages (from-to)349-352
Number of pages4
JournalConvulsive Therapy
Volume5
Issue number4
Publication statusPublished - 1989
Externally publishedYes

Fingerprint

Glycopyrrolate
Electroconvulsive Therapy
Premedication
Cholinergic Antagonists
Heart Arrest
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Shettar, S. M., Grunhaus, L., Pande, A. C., Tandon, R. C., Kronfol, Z., & Haskett, R. F. (1989). Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT. Convulsive Therapy, 5(4), 349-352.

Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT. / Shettar, S. M.; Grunhaus, L.; Pande, A. C.; Tandon, R. C.; Kronfol, Ziad; Haskett, R. F.

In: Convulsive Therapy, Vol. 5, No. 4, 1989, p. 349-352.

Research output: Contribution to journalArticle

Shettar, SM, Grunhaus, L, Pande, AC, Tandon, RC, Kronfol, Z & Haskett, RF 1989, 'Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT', Convulsive Therapy, vol. 5, no. 4, pp. 349-352.
Shettar SM, Grunhaus L, Pande AC, Tandon RC, Kronfol Z, Haskett RF. Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT. Convulsive Therapy. 1989;5(4):349-352.
Shettar, S. M. ; Grunhaus, L. ; Pande, A. C. ; Tandon, R. C. ; Kronfol, Ziad ; Haskett, R. F. / Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT. In: Convulsive Therapy. 1989 ; Vol. 5, No. 4. pp. 349-352.
@article{7672262aec954dbd8bd6473de86c8034,
title = "Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT",
abstract = "The immediate effects of electroconvulsive therapy (ECT) on cardiac conduction, with or without anticholinergic (glycopyrrolate) premedication, were systematically assessed in 19 patients. The resumption of cardiac rhythm after ECT was significantly delayed in treatments without glycopyrrolate. There was no apparent clinical impact of this phenomenon, even though some patients showed asystole of up to 6 s during nonglycopyrrolate treatments.",
author = "Shettar, {S. M.} and L. Grunhaus and Pande, {A. C.} and Tandon, {R. C.} and Ziad Kronfol and Haskett, {R. F.}",
year = "1989",
language = "English",
volume = "5",
pages = "349--352",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT

AU - Shettar, S. M.

AU - Grunhaus, L.

AU - Pande, A. C.

AU - Tandon, R. C.

AU - Kronfol, Ziad

AU - Haskett, R. F.

PY - 1989

Y1 - 1989

N2 - The immediate effects of electroconvulsive therapy (ECT) on cardiac conduction, with or without anticholinergic (glycopyrrolate) premedication, were systematically assessed in 19 patients. The resumption of cardiac rhythm after ECT was significantly delayed in treatments without glycopyrrolate. There was no apparent clinical impact of this phenomenon, even though some patients showed asystole of up to 6 s during nonglycopyrrolate treatments.

AB - The immediate effects of electroconvulsive therapy (ECT) on cardiac conduction, with or without anticholinergic (glycopyrrolate) premedication, were systematically assessed in 19 patients. The resumption of cardiac rhythm after ECT was significantly delayed in treatments without glycopyrrolate. There was no apparent clinical impact of this phenomenon, even though some patients showed asystole of up to 6 s during nonglycopyrrolate treatments.

UR - http://www.scopus.com/inward/record.url?scp=0024819662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024819662&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 349

EP - 352

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 4

ER -